Investigative and Clinical Urology

The Korean Urological Association (대한비뇨의학회)
권호 표지

Clusterin Expression and Apoptosis in Transitional Cell Carcinoma of the Bladder

방광 이행상피세포암종에서 Clusterin 단백의 발현과 세포고사

Park, Hyun-Jung;Lee, Ho-Jung;Yum, Yoon-Hee;Yoo, Tag-Keun;Kang, Jeong-Yoon
박현정;이호정;염윤희;유탁근;강정윤

  • Published : 20070400
⟨ Previous Next ⟩

Abstract

The clusterin expression has been associated with tumorigenesis of various malignancies, including tumors of the prostate, colon and breast. Furthermore, the expression of clusterin is modulated by many factors that are believed to regulate tumor growth and apoptosis. We studied the clusterin expression in transitional cell carcinoma(TCC) of the bladder and we investigated its correlation with apoptosis. Materials and Methods: Eighty five bladder tumor specimens from radical cystectomy or transurethral resection were subjected to immunohistochemical clusterin staining with Ig G clusterin Ab. We examined the immunohistochemical localization of clusterin, and this was followed by TUNEL staining to detect the apoptotic cells. After double-staining with Hoechst 33258, we detected the apoptotic cells under a fluorescence microscope and we calculated the apoptotic index. Results: Invasive TCC showed a stronger positive expression of clusterin as compared with superficial TCC, but the positivity of the clusterin expression was not in proportion to the tumor grade. The apoptotic indices of cancer were 0.52⁑0.28%, 0.30⁑0.16% and 0.17⁑0.11% in Grade I, Grade II and Grade III superficial TCC, respectively, and it was 0.23⁑0.13% in Grade III invasive TCC. Apoptotic cells were not detected in the cancer cells stained with clusterin. Conversely, clusterin was not expressed in the cells showing apoptosis. Conclusions: These results suggest that clusterin could be used as a marker to provide prognostic information for the TCC patients. The apoptotic index revealed that apoptosis and the clusterin expression have correlation with transitional cell cancer. Further study will be needed to clarify the role of clusterin as a therapeutic target for cancer treatment.

Keywords

References

  1. Trougakos IP, Gonos ES. Clusterin/apolipoprotein J in human aging and cancer. Int J Biochem Cell Biol 2002;34:1430-48 https://doi.org/10.1016/S1357-2725(02)00041-9
  2. Trougakos IP, So A, Jansen B, Gleave ME, Gonos ES. Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress. Cancer Res 2004;64:1834-42 https://doi.org/10.1158/0008-5472.CAN-03-2664
  3. Cheng CY, Chen CL, Feng ZM, Marshall A, Bardin CW. Rat clusterin isolated from primary Sertoli cell-enriched culture medium is sulfated glycoprotein-2 (SGP-2). Biochem Biophys Res Commun 1988;155:398-404 https://doi.org/10.1016/S0006-291X(88)81099-4
  4. Fritz IB, Burdzy K, Setchell B, Blaschuk O. Ram rete testis fluid contains a protein (clusterin) which influences cell-cell interactions in vitro. Biol Reprod 1983;28:1173-88 https://doi.org/10.1095/biolreprod28.5.1173
  5. Sensibar JA, Sutkowski DM, Raffo A, Buttyan R, Griswold MD, Sylvester SR, et al. Prevention of cell death induced by tumor necrosis factor alpha in LNCaP cells by overexpression of sulfated glycoprotein-2 (clusterin). Cancer Res 1995;55: 2431-7
  6. Flanagan L, Van Weelden K, Ammerman C, Ethier SP, Welsh J. SUM-159PT cells: a novel estrogen independent human breast cancer model system. Breast Cancer Res Treat 1999; 58:193-204 https://doi.org/10.1023/A:1006331716981
  7. Leskov KS, Klokov DY, Li J, Kinsella TJ, Boothman DA. Synthesis and functional analyses of nuclear clusterin, a cell death protein J Biol Chem 2003;278:11590-600 https://doi.org/10.1074/jbc.M209233200
  8. Miyake H, Gleave M, Kamidono S, Hara I. Overexpression of clusterin in transitional cell carcinoma of the bladder is related to disease progression and recurrence. Urology 2002; 59:150-4 https://doi.org/10.1016/S0090-4295(01)01484-4
  9. Miyake H, Hara I, Kamidono S, Gleave ME. Synergistic chemsensitization and inhibition of tumor growth and metastasis by the antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model. Clin Cancer Res 2001;7:4245-52
  10. Kruger S, Mahnken A, Kausch I, Feller AC. Value of clusterin immunoreactivity as a predictive factor in muscle-invasive urothelial bladder carcinoma. Urology 2006;67:105-9 https://doi.org/10.1016/j.urology.2005.04.043
  11. July LV, Beraldi E, So A, Fazli L, Evans K, English JC, et al. Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivo. Mol Cancer Ther 2004;3:223-32 https://doi.org/10.4161/cbt.3.2.775
  12. Chen X, Halberg RB, Ehrhardt WM, Torrealba J, Dove WF. Clusterin as a biomarker in murine and human intestinal neoplasia. Proc Natl Acad Sci USA 2003;100:9530-5 https://doi.org/10.1073/pnas.1233633100
  13. Xie MJ, Motoo Y, Su SB, Mouri H, Ohtsubo K, Matsubara F, et al. Expression of clusterin in human pancreatic cancer. Pancreas 2002;25:234-8 https://doi.org/10.1097/00006676-200210000-00004
  14. Zellweger T, Kiyama S, Chi K, Miyake H, Adomat H, Skov K, et al. Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumour model. BJU Int 2003;92:463-9 https://doi.org/10.1046/j.1464-410X.2003.04349.x
  15. Miyake H, Hara I, Kamidono S, Gleave ME, Eto H. Resistance to cytotoxic chemotherapy-induced apoptosis in human prostate cancer cells is associated with intracellular clusterin expression. Oncol Rep 2003;10:469-73
  16. Scaltriti M, Brausi M, Amorosi A, Caporali A, D'Arca D, Astancolle S, et al. Clusterin (SGP-2, ApoJ) expression is downregulated in low- and high-grade human prostate cancer. Int J Cancer 2004;108:23-30 https://doi.org/10.1002/ijc.11496
  17. Pucci S, Bonanno E, Pichiorri F, Angeloni C, Spagnoli LG. Modulation of different clusterin isoforms in human colon tumorigenesis. Oncogene 2004;23:2298-304 https://doi.org/10.1038/sj.onc.1207404
  18. Yoon JH, Lee JH, Yeom BW, Won NH, Yoon DK. Expression of osteopontin and clusterin in transitional cell carcinoma of the bladder. Korean J Urol 2005;46:341-6
  19. Steinberg J, Oyasu R, Lang S, Sintich S, Rademaker A, Lee C, et al. Intracellular levels of SGP-2 (Clusterin) correlate with tumor grade in prostate cancer. Clin Cancer Res 1997;3:1707-11
  20. Redondo M, Villar E, Torres-Munoz J, Tellez T, Morell M, Petito CK. Overexpression of clusterin in human breast carcinoma. Am J Pathol 2000;157:393-9 https://doi.org/10.1016/S0002-9440(10)64552-X
  21. Miyake H, Hara S, Zellweger T, Kamidono S, Gleave ME, Hara I. Acquisition of resistance to Fas-mediated apoptosis by overexpression of clusterin in human renal-cell carcinoma cells. Mol Urol 2001;5:105-11 https://doi.org/10.1089/10915360152559585
  22. Criswell T, Klokov D, Beman M, Lavik JP, Boothman DA. Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein. Cancer Biol Ther 2003;2:372-80 https://doi.org/10.4161/cbt.2.4.430